New report outlines recommendations for ensuring that pregnant women receive potentially life-saving vaccines
Quick Read
No Cash, No Heart. Transplant Centers Need to Know You Can PayDecember 4, 2018 |
When a Michigan woman was told to raise $10,000 for a heart transplant, outrage spread on social media. But experts say “wallet biopsies” are common
Quick Read
Chronically Ill, Traumatically Billed: The $123,000 Medicine For MSNovember 28, 2018 |
Shereese Hickson’s multiple sclerosis was flaring again. Spasms in her legs and other symptoms were getting worse. She could still walk and take care of her son six years after doctors diagnosed the disease, which attacks the central nervous system
Quick Read
Watch live online now – FDA Drug Shortages Task Force Public Meeting on Identifying the Root Causes of Drug Shortages and Finding Enduring Solutions – presenters include our Yoram Unguru
Quick Read
Why Don’t We Have Vaccines Against Everything?November 20, 2018 |
Money is just the obvious obstacle. A few diseases, like H.I.V., so far have outwitted both the immune system and scientists
Quick Read
Two years into Maribel’s recovery and treatment, David’s boss gathered his staff into his office. Don’t worry, he said, business is good. Your jobs are safe. But there would be one change: Health insurance offered through the company would soon be discontinued. It had simply become too expensive
Quick Read
When Hospitals Merge to Save Money, Patients Often Pay MoreNovember 14, 2018 |
The nation’s hospitals have been merging at a rapid pace for a decade, forming powerful organizations that influence nearly every health care decision consumers make. The hospitals have argued that consolidation benefits consumers with cheaper prices from coordinated services and other savings
Quick Read
As Social Media ‘Influencers,’ Patients Are Getting a Voice.November 13, 2018 |
And pharma is ready to pay up. Anne Marie Ciccarella is not a doctor, though she spends a great deal of time with them. She’s not a researcher, though she routinely pores over scientific papers on cancer. And even though she spent most of her career at an accounting firm, she’s getting paid by drug companies for her opinions
Quick Read